Raymond James & Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $5.66M | Buy |
116,677
+1,958
| +2% | +$95K | ﹤0.01% | 1572 |
|
2024
Q2 | $4.59M | Buy |
114,719
+16,574
| +17% | +$663K | ﹤0.01% | 1637 |
|
2024
Q1 | $4.31M | Buy |
98,145
+5,486
| +6% | +$241K | ﹤0.01% | 1689 |
|
2023
Q4 | $5.73M | Buy |
92,659
+39,916
| +76% | +$2.47M | ﹤0.01% | 1444 |
|
2023
Q3 | $2.43M | Sell |
52,743
-2,425
| -4% | -$112K | ﹤0.01% | 1895 |
|
2023
Q2 | $3.17M | Buy |
55,168
+31,607
| +134% | +$1.82M | ﹤0.01% | 1776 |
|
2023
Q1 | $884K | Buy |
23,561
+483
| +2% | +$18.1K | ﹤0.01% | 2510 |
|
2022
Q4 | $647K | Sell |
23,078
-2,834
| -11% | -$79.4K | ﹤0.01% | 2701 |
|
2022
Q3 | $728K | Buy |
25,912
+7,629
| +42% | +$214K | ﹤0.01% | 2580 |
|
2022
Q2 | $636K | Buy |
18,283
+1,591
| +10% | +$55.3K | ﹤0.01% | 2745 |
|
2022
Q1 | $599K | Buy |
+16,692
| New | +$599K | ﹤0.01% | 2944 |
|
2021
Q1 | – | Sell |
-13,666
| Closed | -$275K | – | 3826 |
|
2020
Q4 | $275K | Sell |
13,666
-1,481
| -10% | -$29.8K | ﹤0.01% | 3147 |
|
2020
Q3 | $284K | Buy |
15,147
+1,470
| +11% | +$27.6K | ﹤0.01% | 2971 |
|
2020
Q2 | $307K | Buy |
+13,677
| New | +$307K | ﹤0.01% | 2891 |
|
2019
Q3 | – | Sell |
-38,231
| Closed | -$807K | – | 3488 |
|
2019
Q2 | $807K | Buy |
38,231
+1,944
| +5% | +$41K | ﹤0.01% | 2341 |
|
2019
Q1 | $741K | Sell |
36,287
-2,873
| -7% | -$58.7K | ﹤0.01% | 2382 |
|
2018
Q4 | $779K | Sell |
39,160
-452
| -1% | -$8.99K | ﹤0.01% | 2230 |
|
2018
Q3 | $762K | Buy |
39,612
+4,563
| +13% | +$87.8K | ﹤0.01% | 2418 |
|
2018
Q2 | $535K | Buy |
35,049
+1,297
| +4% | +$19.8K | ﹤0.01% | 2627 |
|
2018
Q1 | $633K | Buy |
33,752
+7,989
| +31% | +$150K | ﹤0.01% | 2418 |
|
2017
Q4 | $496K | Sell |
25,763
-455
| -2% | -$8.76K | ﹤0.01% | 2528 |
|
2017
Q3 | $469K | Buy |
+26,218
| New | +$469K | ﹤0.01% | 2513 |
|